Bionovo Inc. announced today the publication of results from its study on the inhibitory effect of tamoxifen on estrogen receptor beta gene regulation. The results of the study which will be published in Molecular and Cellular Endocrinology demonstrate that tamoxifen inhibits the beneficial effects of ERb in the prevention of breast cancer cell proliferation.
view original content